Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Youchao Jia
Observed names:
Jia Youchao,
Jia, Youchao,
Y. Jia
Institution:
Affiliated Hospital of Hebei University
Observed institutions:
Guangxi Medical University,
Chinese PLA General Hospital,
Affiliated Hospital of Hebei University,
Hebei University
ORCID:
0000-0001-9191-5836
Observed ORCIDs:
0000-0001-9191-5836,
0000-0003-4231-7850
OpenAlex ID:
A5100646969
Genistein inhibits A549 human lung cancer cell proliferation via miR-27a and MET signaling
2016
·
Yang Yang
, Aimin Zang
, et al.
·
Oncology Letters
·
74
PDF
FBI-1 enhanced the resistance of triple-negative breast cancer cells to chemotherapeutic agents via the miR-30c/PXR axis
2020
·
Hua Yang
, Lili Ren
, et al.
·
Cell Death and Disease
·
45
PDF
The clinical and prognostic value of polo-like kinase 1 in lung squamous cell carcinoma patients: immunohistochemical analysis
2017
·
Hefei Li
, Haibo Wang
, et al.
·
Bioscience Reports
·
38
MicroRNA-146a rs2910164 polymorphism is associated with susceptibility to non-small cell lung cancer in the Chinese population
2014
·
Youchao Jia
, Aimin Zang
, et al.
·
Medical Oncology
·
38
MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner
2016
·
Yanhong Shang
, Aimin Zang
, et al.
·
Biomedicine & Pharmacotherapy
·
32
A Multicenter Phase2 Trial of Linperlisib in Relapsed or Refractory Peripheral T/NK Cell Lymphomas
2023
·
Yuqin Song
, Zengjun Li
, et al.
·
Blood
·
11
Two case reports of non-small cell lung cancer patients harboring acquired EGFR T790M-cis-C797S benefit from immune checkpoint inhibitor combined with platinum-based doublet chemotherapy
2022
·
Zizheng Song
, Guanying Ren
, et al.
·
Annals of Translational Medicine
·
10
PDF
Cullin7 in tumor development: a novel potential anti-cancer target
2021
·
Yumiao Li
, Aiming Zang
, et al.
·
Neoplasma
·
9
PDF
Cullin7 induces docetaxel resistance by regulating the protein level of the antiapoptotic protein Survivin in lung adenocarcinoma cells
2023
·
Yumiao Li
, Wenyi He
, et al.
·
Journal of Thoracic Disease
·
8
PDF
TES was epigenetically silenced and suppressed the epithelial–mesenchymal transition in breast cancer
2014
·
Yang Yongbin
, Li Jinghua
, et al.
·
Tumor Biology
·
8
Comparative safety of different first-line treatments for chronic lymphocytic leukemia/small lymphocytic lymphoma: A systematic review and network meta-analysis
2024
·
Qingyun Liu
, Jiaxing Zhao
, et al.
·
Annals of Hematology
·
5
PDF
The synergized diagnostic value of VTQ with chemokine CXCL13 in lung tumors
2023
·
Xu Zhang
, Yejian Lu
, et al.
·
Frontiers in Oncology
·
4
PDF
Advances in Preclinical Models of Small Cell Lung Cancer
2019
·
Guofa Zhao
, Zhenze Zhao
, et al.
·
Med One
·
3
miRNA-486 and miRNA-499 in human plasma evaluate the clinical stages of lung cancer and play a role as a tumor suppressor in lung tumorigeneisis not pathogenesis
2016
·
Youchao Jia
, Aimin Zang
, et al.
·
Bangladesh Journal of Pharmacology
·
3
PDF
MBS303, a Novel 2:1 CD20×CD3 Bispecific Antibody, Demonstrated a Favorable Safety and Potent Antitumor Activity in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma: Preliminary Results from a Phase Ⅰ, Dose-Escalation Trial
2024
·
Yuqin Song
, Haiyan Yang
, et al.
·
Blood
·
2
PDF
A phase I open-label study of a novel IL-2Rβ/γ cytokine agonist, LTC004, in patients with advanced or metastatic solid tumors.
2024
·
Jifang Gong
, Lin Shen
, et al.
·
Journal of Clinical Oncology
·
2
PDF
Obinutuzumab plus bendamustine as first-line therapy for indolent B-cell lymphomas: a prospective multicenter open-label study
2026
·
Yuting Yan
, Xinyang Hu
, et al.
·
MedScience
EP.11.19 Efficacy and Safety of Continuing Tislelizumab After Progression of First-Line Tislelizumab in Patients With Advanced NSCLC
2025
·
B. Qin
, X. Ge
, et al.
·
Journal of Thoracic Oncology
586 | Obinutuzumab Combined With Bendamustine in the Treatment of Mature B‐cell Lymphoma: an Open‐label, Multicenter Study
2025
·
Y. Yan
, X. Hu
, et al.
·
Hematological Oncology
PDF
P2.01-45 Clinico-Molecular Characteristics and Prognostic Outcomes of TP53 Mutated Patients with Advanced Non-Small Cell Lung Cancer
2019
·
Z. Song
, L. Hu
, et al.
·
Journal of Thoracic Oncology
PDF
Applications of molecular detection of lung cancer in developing countries
2014
·
Youchao Jia
, Yanhong Shang
, et al.
·
Guoji zhongliuxue zazhi
Show more works
View as search
Works count:
23
Citation count:
292
H-index:
8
I10-index:
7
Year
Topic
Type